Chirag Paswan says India working with global bodies on nutraceutical regulations

New Delhi: India is working with global regulatory bodies, like Codex Alimentarius Commission, to formulate regulations for the nutraceutical industry, which has huge growth potential, Food Processing Industries Minister Chirag Paswan said on Tuesday.

“Nutraceuticals are again one of the fastest-growing industries. When it comes to this particular sector, we need to have regulations in place,” Paswan told reporters on the sidelines of an Assocham event.

“We are working closely with international regulatory bodies like Codex to have formal regulations so that the industry can grow.”

The scope of this industry is massive, and since it is new, numerous reforms and policies need to be implemented, for which the government is currently in the process, he added.

Paswan, addressing the event, noted that the government is ready to address the gaps in the sector and urged stakeholders to suggest policy reforms.

He said the government is focusing on nutritional security, alongside food security.

India’s nutraceutical industry is experiencing rapid growth, fuelled by rising health awareness and preventive healthcare trends.

Nutraceuticals fall primarily under the Food Safety and Standards Authority of India (FSSAI) via the Food Safety and Standards Act, 2006. Core rules include FSS (Health Supplements, Nutraceuticals, etc.) Regulations, 2016, covering licensing, labelling, advertising claims, and contaminants.

Food business operators need FSSAI licenses for manufacturing and sales. Labelling must detail purpose, target groups, usage instructions, and precautions; no genetically modified ingredients are permitted currently.

Related Posts

‘Did patients come dancing?’ – Rajasthan minister’s remarks about kidney failure case spark row

On Thursday, Congress workers held protests against the “degrading medical conditions of Rajasthan” and attempted to enter the hospital premises. Rajasthan Health Minister Gajendra Singh Khinvsar’s remarks about women diagnosed…

Price cap on 2 key cancer drugs increased by 50%

NEW DELHI: Amid concerns over shortages of two critical cancer medicines, National Pharmaceutical Pricing Authority has approved a 50% hike in ceiling prices of Carboplatin and Cisplatin injections, citing escalating…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

‘Did patients come dancing?’ – Rajasthan minister’s remarks about kidney failure case spark row

‘Did patients come dancing?’ – Rajasthan minister’s remarks about kidney failure case spark row

Price cap on 2 key cancer drugs increased by 50%

Price cap on 2 key cancer drugs increased by 50%

Hospitals can’t force patients to buy medicines from their pharmacies: Maha FDA

Hospitals can’t force patients to buy medicines from their pharmacies: Maha FDA

IIT Bhubaneswar researchers develop portable device for accurate arsenic detection

IIT Bhubaneswar researchers develop portable device for accurate arsenic detection

Bribe of Rs 3 crore: Delhi Police inspector held, senior public servant under CBI scanner

Bribe of Rs 3 crore: Delhi Police inspector held, senior public servant under CBI scanner

No raids till further orders: Maharashtra tells Bombay HC in Patanjali labelling case

No raids till further orders: Maharashtra tells Bombay HC in Patanjali labelling case